Archive for April, 2010

Contract Research Organization – (CRO) – Veristat

Thursday, April 29th, 2010

Veristat as Your Contract Research Organization (CRO)

As illustrated in the article below, it is time, more than ever to utilize a Contract Research Organization (CRO) for pharmaceutical, medical device, or biotech clinical studies.  As discussed, a CRO can help control costs, meet abbreviated deadlines, and enhance competitiveness. Veristat assists in these efforts by providing a source for your company to contract out Clinical Monitoring, Data Management, Biostats, Programming, Medical Writing, and CDISC Implementation services to reduce your overhead costs.

http://www.officialwire.com/main.php?action=posted_news&rid=126458

As an innovative mid-sized CRO, Veristat offers the ease and flexibility to adapt as your trial needs change throughout the many phases of the program.   Veristat is the answer to the question “Which CRO can best meet your clinical trial needs while reducing costs?” Contact Nicole Powell at info@veristat.com to learn more about Veristat’s unique partnership approach through your clinical trials.

CDISC Implementation: The First in Recognition

Friday, April 23rd, 2010

The First in Recognition

Veristat is pleased to announce that the CDISC Technical Leadership Committee has thoroughly reviewed our qualifications for the development of study/trial design datasets and is now recognizing us as the first Registered Solutions Provider (RSP) supporting this CDISC model.

This is an exciting development for our CDISC Implementation Team who has worked hard to establish themselves has subject matter experts on the various CDISC standards.  Veristat was originally recognized as an RSP back in September 2009 supporting the ADaM, CDASH, Define.XML and SDTM models.

Please reference CDISC RSP standards:  http://www.cdisc.org/rsp-chart

For more information about our CDISC implementation services and what Veristat can do to assist your clinical trial needs please contact Nicole Powell at info@veristat.com.

Living our mission, adopting CDISC Implementation

Tuesday, April 13th, 2010

Since CDISC’s inception, two of the organization’s core principles have been to “lead the development of standards that improve efficiency while supporting the scientific nature of clinical research” and to “maintain a global, multidisciplinary, cross-functional composition for CDISC and its working groups” (CDISC Mission & Principles).  We highlight these two principles as we strongly believe neither can be achieved in isolation from the other.

At Veristat, a full service CRO, we pride ourselves on having modeled our CDISC Implementation Services team and approach in keeping with these ideals.  This team is comprised of in-house Statistical Programmers, Biostatisticians, Clinical Data Managers, Data Standards Managers, Database Developers, Medical Writers, and medical experts who have experience in all phases of drug, biologic, and device development cycles.  Their collective approach is to utilize CDISC standards as a common language in order to effectively share their experiences and draw upon each other’s expertise.  This diverse collaboration and common logic transforms those concepts and practices into high quality and cost-efficient study deliverables, clear submissions that conform to regulatory standards, and an ever-increasing number of experts within Veristat and the companies we work with.

Whether conducting gap analyses of clinical documents and source data on legacy trials, identifying the impact of missing or nonconforming data on analyses, developing a new domain that fits the structure of the observation classes defined in the SDTM model, or designing CRFs, operational databases, and analysis datasets that blend both a sponsor’s needs with the CDISC guidance and regulatory requirements, our CDISC Implementation Services team has seen and done it all.  As early adopters of CDISC standards, and subsequently early appraisers of the inherent challenges and benefits, Veristat can confidently affirm that CDISC continues to meet and exceed its core mission statement and principles which are synonymous with our own (Veristat Mission).

Veristat Announces CDISC News

Wednesday, April 7th, 2010

Veristat Announces CDISC News

In February of this year, CDISC posted a summary of their most recent Executive Committee Meeting with representatives from CDER and CBER.  As a Registered Solutions Provider, and with our experience in CDISC implementation, Veristat promotes the use of CDISCas a global standard.

From the linked article Veristat brings particular attention to the following two quotes:

“CDER and CBER are moving forward with an aggressive and expanded effort to encourage the use of CDISC standards (including SDTM and ADaM)”  (http://www.cdisc.org/stuff/contentmgr/files/0/d3c7e8b6690f991da920e7e60dee0568/misc/fda_cdiscmeeting1feb10summarybodfin.pdf)

“Use of the CDISC standards, refined and developed as needed, will result in high quality submissions that will be reviewed more quickly. As such the likelihood of an approval on the first review cycle will increase.”

(http://www.cdisc.org/stuff/contentmgr/files/0/d3c7e8b6690f991da920e7e60dee0568/misc/fda_cdiscmeeting1feb10summarybodfin.pdf)

This confirms our experience and understanding that both industry and the agency value data standards.  Veristat will continue to contribute to the development and promotion of CDISC standards as a means to present and analyze data in an ethical and efficient manner.

Executive Summary of FDA/CDISC Meeting

For more information on our CDISC services and how we can assist your clinical trial program, please contact info@veristat.com